https://orcid.org/0000-0001-9239-0103
References
- Almuqbil M, Alshaikh FY, Altwaijri W, et al. Epidemiology and outcomes of neurofibromatosis type I (NF-I): multicenter tertiary experience. J Multidiscip Healthc. 2024;17:1303–1314. doi:10.2147/JMDH.S454921
- Wolfertz N, Bohm L, Keitel V, et al. Epidemiology, management, and outcome of infection, sepsis and septic shock in a German emergency department (EpiSEP study). Front Med. 2022;9:997992. doi:10.3389/fmed.2022.997992
- Adil A, Koritala T, Munakomi S, et al. Neurofibromatosis type 1. NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health; 2024.
- Evans DG, Howard E, Giblin C, et al. Birth incidence and prevalence of tumor-prone syndromes: estimates from a UK family genetic register service. Am J Med Genet A. 2010;152A(2):327–332. doi:10.1002/ajmg.a.33139
- DeBella K, Szudek J, Friedman JM. Use of the national institutes of health criteria for diagnosis of neurofibromatosis 1 in children. Pediatrics. 2000;105(3 Pt 1):608–614. doi:10.1542/peds.105.3.608